The News Review:

- Louisiana Governor Jindal Marks Groundbreaking For Baton Rouge …
- Ahead of the Bell: Parexel International
- Collaboration key as Arizona’s fledgling biotech hub weathers …
- Researchers Zero In on GI Cancers
- PFC Pharma Focus Expands its Clinical Research Services to South …
- To Fight Infectious Disease Medical Research Turns To Philosophy …
- » Clinical Research Associates

Louisiana Governor Jindal Marks Groundbreaking For Baton Rouge …
Bayou Buzz LA 
Today’s groundbreaking at Pennington also marks the one year anniversary of Governor Jindal’s inauguration. “This groundbreaking represents a monumental step in Pennington’s continued expansion and ongoing efforts to attract top research talent and clinical research funding to our state” said Governor Jindal. “In essence – this is a new cylinder in the economic engine that is Pennington.
Related from Dmdreams: Louisiana Business: Corps Construction Bids Digital Media New …

Ahead of the Bell: Parexel International
MSNBC 
50 noting that management said the amount of at-risk clients remains immaterial. “PiperJaffray analyst Sean W. Wieland reaffirmed a “Neutral” rating and $8 price target but said clinical research organizations’ results will likely be weak this earnings season. Tighter spending within the drug development industry and a decline in foreign exchange benefits is likely to hurt revenue throughout the outsourced clinical research sector. Companies like Charles River Laboratories Inc.

Collaboration key as Arizona’s fledgling biotech hub weathers …
Bizjournals.com NC 
Clinical trials of the new drug currently called VTX-2337 are being conducted at TGen Clinical Research Services at Scottsdale Healthcare and at the Mayo Clinic in Scottsdale. If that yearlong test is successful the drug will enter a phase two trial to test its effectiveness on tumors said Dr. Ramesh Ramanathan medical director of TGen Clinical Research Services. Growing effortsAn even bigger collaboration was forged last year between TGen and two Seattle-based research institutes to create an international partnership to spur discovery and innovation in personalized medicine molecular biology and systems biology in Luxembourg. The Phoenix-based Partnership for Personalized Medicine which includes scientists from TGen and the.

Researchers Zero In on GI Cancers
U.S. News & World Report DC 
verall those without significant GERD had a lower risk and those with more GERD had almost 10 times the risk. Those who had GERD more than once a week or who had had GERD for more than 15 years had almost 22 times the risk the researchers said. “These findings indicated to us that there was indeed an interaction of some sort between the EGF gene and GERD in the esophagus” said study author Dr. Cheung a clinical research fellow at the University of Toronto and the Harvard School of Public Health. “This could have important clinical implications for screening. ” A third group of researchers from Germany found that the drug Sandostatin LAR (octreotide LAR) can slow tumor progression in patients with malignant neuroendocrine tumors of the midgut (the lower part of the small intestines) a rare form of cancer.

PFC Pharma Focus Expands its Clinical Research Services to South …
PharmaLive.com (press release) PA 
CM PFC Pharma Focus Expands its Clinical Research Services to South America by Partnering with Blanchard & Asociados SRLSWITZERLAND January 13 2009–PFC Pharma Focus a Swiss Contract Research rganization (CR) has signed a Partnership Agreement with Blanchard y Asociados a clinical research consulting firm based in Argentina in order to provide clinical services and project management services in South America. PFC Pharma Focus headquarter are based in Zurich Switzerland and it has three other offices in Germany India and in Israel. PFC has been establishing partnerships with regional representatives in Europe USA and Canada thus solidifying its presence on the global scene and becoming an important reference in international contract research. Now with the assistance of Blanchard & Asociados extensive training experience and wide-ranging network of experts throughout South America PFC will extend its services to Argentina Brazil Chile and other South American countries. Blanchard & Asociados will offer the same services as those delivered by PFC Head offices and in accordance with the same standards of excellence.

To Fight Infectious Disease Medical Research Turns To Philosophy …
UB News Center NY 
UB dean emeritus of the School of Dental Medicine. For the past four years Smith has been working with the developers of bio-ontologies including the Gene ntology to demonstrate how the lessons learned in philosophy and logic — for example the proper use of definitions and classifications — can lead to improvements which in turn can bring real benefits to biological and clinical research. “The use of ontologies by clinical researchers reflects recognition of the need for common frameworks for integrating data across biological and clinical disciplines” said Smith. “It also reflects increasing efforts by the National Institutes of Health and other bodies to encourage clinical researchers to make their data more easily available to wider groups of researchers. “The new approach to ontology which we pioneered at UB makes it easier to build good quality ontologies in a consistent fashion and to reason with the associated data in a way that is designed to be easily extendible to new diseases and new pathogens” he explained. ther diseases being studied under the ID Consortium established by Smith and Cowell include malaria and other vector-borne diseases tuberculosis infective endocarditis influenza and dengue fever.

» Clinical Research Associates
Hays Pharma UK 
00 per annumLocationSouth Korea14 Jan 2009An exciting opportunity has arisen to join a leading global Contract Research rganisation as an office-based Clinical Research Associate (all levels) in Seoul. The purpose of the job will be toIdentify select initiate and close-out appropriate investigational sites for clinical studies. Recruitment of investigators.